Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CECILIA: Bevacizumab with Carboplatin and Paclitaxel in Cervical Cancer
NCT02467907Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2015
- Primary completion
- Dec 2018
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 2 trial of bevacizumab in Cervical Cancer (CC), sponsored by Roche. Started Jul 2015; status: completed.
02
Drugs
bevacizumab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02467907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467907.